1 / 37

The Evolution of Biotechnology as a Knowledge Industry: Network Movies and Dynamic Analyses of Emergent Structure

The Evolution of Biotechnology as a Knowledge Industry: Network Movies and Dynamic Analyses of Emergent Structure.

LeeJohn
Download Presentation

The Evolution of Biotechnology as a Knowledge Industry: Network Movies and Dynamic Analyses of Emergent Structure

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The Evolution of Biotechnology as a Knowledge Industry: Network Movies and Dynamic Analyses of Emergent Structure • Walter W. Powell Douglas R. White Kenneth W. KoputStanford University UC Irvine University of Arizona Slides by Douglas R. White • Biotechnology as a knowledge-based industry involves extensive reliance on organizational learning. This occurs through networks of dense collaborative ties among organizations. We model the emergence of the industry networkof contractual collaborations from 1988-99 in relation to both firm-level organizational and financial changes.

  2. Network Movie: 1988-99 • The following twelve slides show the evolution of collaborative contracts within the biotech industry • Green ties =Finance • Red ties =Res&Dev • Grey =Finance • LiteBlue =Biotech • Yellow =Pharmaceuticals • Orange =Res.Labs and Universities • DarkBrown =Government (e.g., NIH) • Pink =Miscellaneous

  3. 1988: Lots of Finance, little R&D

  4. 1989: Nucleus of R&D attracts more Finance

  5. 1990: Massive investment in R&D

  6. 1991: The phase transition is complete

  7. 1992: …and then it stops

  8. 1993:

  9. 1994:

  10. 1995:

  11. 1996:

  12. 1997:

  13. 1998:

  14. 1999:

  15. Figure 1: Levels of Network Cohesion: Tricomponents (within dark/red circles) embedded in Bicomponents (circled in medium/green) within Components (in light/yellow circles)

  16. Figure 2: Slow Transitions to Giant Components,1990-1994

  17. Figure 3: Rapid Phase Transition in Bicomponent Growth

  18. Figure 4: Degree(+1) Distributions for the 1-Mode Data

  19. Figure 5 a: Degree(+1) Distributions for the 2-Mode Data

  20. Figure 5 b : Degree(+1) Distributions for the 2-Mode Data(removing zero frequency counts)

  21. Figure 5 c: Exponential for DBFs' degree choosing partners; power-law for partners degree chosen by DBFs

  22. Figure 6: Scatterplot of Biotech degree as chosen by other Biotechs (1-Mode) and as chosers of 2-Mode Partners (v2log=.55+0.52v1og; R-Square=0.15)

  23. Figure 7: The Sexta-component of R&D and Finance Contracts in the Biotech Industry Blue=Biotech, Size of nodes reflects number of finance ties. Brown=government Orange=Research Institutes and Universities Yellow=Pharmaceuticals (f=DBF p=partners)

  24. Figure 7: The Sexta-component of R&D and Finance Contracts in the Biotech Industry Blue=Biotech, Size of nodes reflects number of finance ties. Brown=government Orange=Research Institutes and UniversitiesYellow=Pharmaceuticals (f=DBF p=partners)

  25. Figure 8: 1988

  26. Figure 8: 1989

  27. Figure 8: 1990

  28. Figure 8: 1991

  29. Figure G1: Time Series of Growth Parameters: Mean Growth by Tie Activity, Separately for Form of Partners.

  30. Figure G2: Time Series of Growth Parameters: Mean Growth by Partner Form, Separately for Type of Activity.

  31. Figure G2: Time Series of Growth Parameters: Mean Growth by Partner Form, Separately for Type of Activity.

  32. Figure G1: Time Series of Growth Parameters: Mean Growth by Tie Activity, Separately for Form of Partners. • Left Figure Plots Coefficient of Variation over time for Modal Combinations: Magenta = R&D to Universities and NonProfits, Red = R&D to Government, Green= Finance to Financial, Cyan = Commercial to Biotech, Blue = Commercial to Pharmaceutical and Other For- Profit. • Right Figure Plots Coefficient of Variation for all remaining combinations with no color legend.

  33. Figure 9: Cycles of Learning and Organizational Returns (Powell et al. 1999) Legend 1. Ovals represent network properties, rectangles are performance and outcome measures, while rounded rectangles can be treated as either firm characteristics or outcomes.2. Shadowed components carry over from Powell et al. (1996).

  34. Figure 10 a: Finance and R&D networks of 2219 organizations 1988-1991

  35. Figure 10 b: Finance and R&D networks of 2219 organizations 1992-1995

  36. Figure 10 c: Finance and R&D networks of 2219 organizations 1996-1999

  37. Figure 11: Distance from NIH: R&D and Finance

More Related